MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 52 filers reported holding MUSTANG BIO INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24,347 | -20.8% | 66,412 | -14.7% | 0.00% | – |
| Q4 2022 | $30,731 | -38.5% | 77,819 | -26.4% | 0.00% | – |
| Q3 2022 | $50,000 | -44.4% | 105,712 | -31.2% | 0.00% | – |
| Q2 2022 | $90,000 | -52.4% | 153,738 | -18.0% | 0.00% | – |
| Q1 2022 | $189,000 | -60.9% | 187,542 | -35.5% | 0.00% | – |
| Q4 2021 | $483,000 | -27.8% | 290,604 | +16.9% | 0.00% | – |
| Q3 2021 | $669,000 | +151.5% | 248,606 | +210.0% | 0.00% | – |
| Q2 2021 | $266,000 | -80.8% | 80,190 | -80.7% | 0.00% | – |
| Q1 2021 | $1,382,000 | +84.8% | 416,271 | +110.6% | 0.00% | – |
| Q4 2020 | $748,000 | -21.2% | 197,678 | -34.4% | 0.00% | – |
| Q3 2020 | $949,000 | +143.3% | 301,252 | +145.4% | 0.00% | – |
| Q2 2020 | $390,000 | +1292.9% | 122,753 | +1069.4% | 0.00% | – |
| Q1 2020 | $28,000 | -92.6% | 10,497 | -80.9% | 0.00% | – |
| Q2 2018 | $378,000 | -58.8% | 54,925 | -34.5% | 0.00% | – |
| Q1 2018 | $918,000 | +600.8% | 83,913 | +666.0% | 0.00% | – |
| Q4 2017 | $131,000 | – | 10,955 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
| GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
| Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
| Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
| EMFO, LLC | 32,000 | $32,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
| Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
| Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
| Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |